Chemical inhibitors of 4833422F24Rik can modulate the protein's activity through various biochemical pathways. Acetazolamide, by reducing bicarbonate ion concentrations, can interfere with the function or structural integrity of 4833422F24Rik, assuming its activity is bicarbonate-dependent. Methotrexate, as a dihydrofolate reductase inhibitor, can lead to a decrease in tetrahydrofolate availability, which can impact 4833422F24Rik if its activity necessitates folate derivatives. Allopurinol's inhibition of xanthine oxidase can reduce uric acid production, which can alter the activity of 4833422F24Rik through feedback mechanisms. Aminoguanidine's role in reducing nitric oxide levels can affect nitrosylation status and consequently the activity of 4833422F24Rik. Disulfiram can impede 4833422F24Rik's function if the protein's activity is connected to aldehyde metabolism or requires aldehyde groups for its active conformation, by inhibiting aldehyde dehydrogenase.
In addition, 3-Methyladenine can inhibit 4833422F24Rik by preventing autophagic processes that might be crucial for the protein's turnover and function. Bortezomib, by inhibiting proteasome-mediated degradation, can result in an accumulation of damaged or misfolded proteins, which can interfere with the function of 4833422F24Rik. Chloroquine's ability to raise lysosomal pH can inhibit 4833422F24Rik if an acidic environment or involvement in lysosomal degradation pathways is necessary for the protein's function. Lithium chloride can influence the activity or stability of 4833422F24Rik by altering phosphorylation patterns through its inhibition of GSK-3. Rapamycin's role as an mTOR inhibitor can modulate cellular growth signals that are essential for the protein's expression levels or post-translational modifications. Sorafenib, by targeting tyrosine kinases, can interfere with signaling pathways that regulate the phosphorylation state and functional conformation of 4833422F24Rik. Lastly, Trichostatin A, as a histone deacetylase inhibitor, can affect the chromatin structure and gene accessibility, which in turn can regulate the expression of 4833422F24Rik.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acetazolamide | 59-66-5 | sc-214461 sc-214461A sc-214461B sc-214461C sc-214461D sc-214461E sc-214461F | 10 g 25 g 100 g 250 g 500 g 1 kg 2 kg | $81.00 $177.00 $434.00 $541.00 $883.00 $1479.00 $2244.00 | 1 | |
As a carbonic anhydrase inhibitor, Acetazolamide can inhibit the enzyme 4833422F24Rik by reducing the availability of bicarbonate ions, which may be necessary for the protein's function or its conformational stability. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate, a dihydrofolate reductase inhibitor, can lead to reduced availability of tetrahydrofolate and thereby inhibit the activity of 4833422F24Rik if the protein requires folate derivatives for its catalytic activity. | ||||||
Allopurinol | 315-30-0 | sc-207272 | 25 g | $131.00 | ||
By inhibiting xanthine oxidase, Allopurinol can decrease the production of uric acid, which might interact with 4833422F24Rik or alter its activity through feedback mechanisms. | ||||||
Aminoguanidine hydrochloride | 1937-19-5 | sc-202931 sc-202931A sc-202931B | 10 g 25 g 50 g | $32.00 $43.00 $94.00 | 2 | |
Aminoguanidine, an inhibitor of inducible nitric oxide synthase, may inhibit 4833422F24Rik by reducing nitric oxide levels, which could affect the protein's nitrosylation status and consequently its activity. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram inhibits aldehyde dehydrogenase, which in turn can inhibit 4833422F24Rik if the protein's function is related to aldehyde metabolism or if it requires aldehyde groups to maintain its active conformation. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
As an autophagy inhibitor, 3-Methyladenine can inhibit 4833422F24Rik by preventing autophagic degradation processes that may be essential for the protein's turnover and function. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib, a proteasome inhibitor, can inhibit 4833422F24Rik by blocking the degradation of misfolded or damaged proteins, potentially leading to an accumulation that affects the protein's function. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine can inhibit the lysosomal function by raising the pH, which might inhibit 4833422F24Rik if the protein requires acidic conditions or is involved in the lysosomal degradation pathway. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase 3 (GSK-3), which could inhibit 4833422F24Rik by altering phosphorylation patterns that affect the protein's activity or stability. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR inhibitor, Rapamycin can inhibit 4833422F24Rik by modulating cellular growth signals that may be essential for the protein's expression levels or post-translational modifications. | ||||||